Sort
64,565 grants matching “drug discovery”
CCR Office of Training and Education
$845,633Jonathan Scott Wiest · Division Of Basic Sciences - Nci · ZIJ · FY2018 · CA
TrmD-targeting actinobacterial natural products as next generation antibiotics
$845,545Ya-Ming Hou · Thomas Jefferson University · R01 · FY2021 · AI
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
$845,443Mark Scott Sundrud · Dartmouth-Hitchcock Clinic · R01 · FY2025 · AI
Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis
$845,274Michael R Grever · Ohio State University · UM1 · FY2015 · CA
A new genetic approach for studying prions and other pathogenic protein aggregate
$845,250Ann Hochschild · Harvard Medical School · DP1 · FY2008 · OD
Clinical and Genetic Study of Prescription Opioid Addiction
$845,183Vanessa Troiani · Geisinger Clinic · R01 · FY2017 · DA
Ion Channel Assay for Identifying Influenza Therapeutics
$845,142Benjamin Jacob Doranz · Integral Molecular · R01 · FY2006 · AI
[18F]-PU-AD epichaperome PET imaging probe
$845,131Gabriela Chiosis · Sloan-Kettering Inst Can Research · RF1 · FY2025 · AG
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$845,000Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2021 · CA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$844,999Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$844,999Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Small Molecule Therapeutics for Myocardial Ischemia
$844,903Prakash Narayan · Angion Biomedica Corporation · R44 · FY2006 · HL
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
$844,721Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Intranasal delivery of VGF-derived peptides in a preclinical model of Alzheimer's disease
$844,721Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
The MetaCyc & BioCyc Pathway/Genome Databases (SRI Proposal ECU 14-630)
$844,698Peter D Karp · Sri International · R01 · FY2017 · GM
Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI)
$844,695Wenbing Yun · Sigray, Inc. · R44 · FY2021 · GM
Structural Studies of Opioid Receptors, p 55
$844,634Vadim Cherezov · Scripps Research Institute, The · P01 · FY2014 · DA
PD iPS Cell Line Consortium
$844,623Ole Isacson · Mclean Hospital · U24 · FY2013 · NS
The integrated stress response in cognitive disorders
$844,472Paul Pfaffinger · Baylor College Of Medicine · R01 · FY2025 · NS
CRISPR Genome-Wide sgRNA Library Screening Platform
$844,431Donato Tedesco · Cellecta, Inc. · R44 · FY2018 · HG
Discovery and development of broad spectrum anti-flaviviral drugs
$844,425Mariano A. Garcia-Blanco · Duke University · R01 · FY2011 · AI
Multimodal Qdot Probes for Bioimaging of Cells and Tumors in Small Animals
$844,352Shimon Weiss · University Of California Los Angeles · R01 · FY2008 · EB
INTERDISCIPLINARY APPROACH TO ALZHEIMER DRUG DISCOVERY
$844,145Nathan S. Kline Institute For Psych Res · P01 · FY2001 · AG
Integrated understanding of complex viral network biology in Alzheimer's Disease
$844,112Joel Thomas Dudley · Icahn School Of Medicine At Mount Sinai · R56 · FY2017 · AG
Drug Discovery & Synthesis of Contraceptive Agents
$844,069Gunda I. Georg · University Of Minnesota · U01 · FY2015 · HD